secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLx Pharma Winddown Corp. (—)
CIK:        0001497504
Form:       8-K
Filed at:   2023-05-26T23:59:59+00:00
Accession:  0001193805-23-000799
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 1.01, 1.03, 2.01, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PLx Pharma Winddown Corp. completes sale of substantially all assets following Chapter 11 approval
--------------------------------------------------------------------------------

- Sale to PLx Acquisition Company, LLC consummated on May 26, 2023, after Bankruptcy Court approval on May 25.
- Company changed name to PLx Pharma Winddown Corp.; common stock trades on OTC Pink under PLXPQ.
- Amendment to Asset Purchase Agreement clarified excluded assets, inventory definitions; Buyer Deficiency Claim eliminated.
- Monthly operating reports filed for period April 13-30, 2023, covering initial bankruptcy period.
- Company cautions trading in common stock is highly speculative; holders may receive no recovery.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1497504/000119380523000799/0001193805-23-000799-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1497504/000119380523000799/e618671_8k-plx.htm
  HTML page:      https://secwatch.observer/filing/0001193805-23-000799

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer